XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 165,648 $ 131,541
Marketable securities 0 138,372
Accounts receivable 8,130 16,266
Prepaid expenses and other current assets 3,113 3,136
Total current assets 176,891 289,315
Property and equipment, net 4,287 14,497
Right-of-use assets 17,583 32,554
Restricted cash and other non-current assets 2,990 5,223
Total assets 201,751 341,589
Current liabilities:    
Accounts payable 3,163 5,493
Accrued expenses 47,522 45,859
Liability for sale of future revenues, current 5,000 5,000
Deferred revenue, current 0 6,221
Operating lease liabilities 6,088 14,652
Total current liabilities 61,773 77,225
Operating lease liabilities, net of current portion 13,564 20,380
Liability for sale of future revenues - non-current 54,069 52,434
Deferred revenue, net of current portion 54,204 54,204
Other non-current liabilities 4,688 3,072
Total liabilities 188,298 207,315
Stockholders’ equity    
Preferred stock, $0.0001 par value per share: 5,000,000 shares authorized; no shares issued or outstanding 0 0
Common stock, $0.0001 par value per share: 390,000,000 and 195,000,000 shares authorized at September 30, 2025 and December 31, 2024, respectively; 93,264,421 and 82,734,696 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 9 8
Additional paid-in capital 1,636,327 1,602,441
Accumulated other comprehensive income 0 268
Accumulated deficit (1,622,883) (1,468,443)
Total stockholders’ equity 13,453 134,274
Total liabilities and stockholders’ equity $ 201,751 $ 341,589